Vicriviroc (SCH 417690) is an orally active CCR5 antagonist with the IC50 of 10 nM, and also inhibts MIP-1alpha and intracellular calcium release induced by the ligand RANTES (10 nM) with the IC50 values of 0.91 nM and 16 nM,,respectively. Vicriviroc can inhibits human immunodeficiency virus type 1 (HIV-1) infection, and can also used for study of cancer[1][2].
Molecular Weight:
533.63
CAS Number:
[306296-47-9]
Formula:
C28H38F3N5O2
Target:
CCR,HIV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
